Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Joseph Glorioso

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Procedures

Gene Therapy

Devices

Gene Transfer Techniques

Anatomy

Physiology

Genes & Molecular Sequences

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
77
Fink, David
60
Goins, William
40
Wolfe, Darren
39
Mata, Marina
38
Levine, Myron
33
Krisky, David
22
Oligino, Thomas
21
Marconi, Pierfrancesco
19
Huang, Shaohua
19
Cohen, Justus
14
Goss, James
13
Burton, Edward
12
Poliani, PL
12
Wechuck, James
11
DeLuca, Neal

Sign-in to see all Coauthors

Publications

TOP 3
Goss J R; Gold M S; Glorioso J C
HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.
Grandi Paola; Peruzzi Pierpaolo; Reinhart Bonnie; Cohen Justus B; Chiocca E Antonio; Glorioso Joseph C
Design and application of oncolytic HSV vectors for glioblastoma therapy.
Goins W F; Goss J R; Chancellor M B; de Groat W C; Glorioso J C; Yoshimura N
Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Joseph Glorioso (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Goss J R; Gold M S; Glorioso J C
HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.
Gene therapy 2009;16(4):493-501.
2009: Grandi Paola; Peruzzi Pierpaolo; Reinhart Bonnie; Cohen Justus B; Chiocca E Antonio; Glorioso Joseph C
Design and application of oncolytic HSV vectors for glioblastoma therapy.
Expert review of neurotherapeutics 2009;9(4):505-17.
2009: Goins W F; Goss J R; Chancellor M B; de Groat W C; Glorioso J C; Yoshimura N
Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.
Gene therapy 2009;16(4):558-69.
2009: Uchida Hiroaki; Shah Waris A; Ozuer Ali; Frampton Arthur R; Goins William F; Grandi Paola; Cohen Justus B; Glorioso Joseph C
Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.
Journal of virology 2009;83(7):2951-61.
2009: Grant Kyle G; Krisky David M; Ataai Mohammed M; Glorioso Joseph C
Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Biotechnology and bioengineering 2009;102(4):1087-97.
2009: Glorioso Joseph C; Fink David J
Herpes vector-mediated gene transfer in the treatment of chronic pain.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(1):13-8.
2009: Kato R; Wolfe D; Coyle C H; Wechuck J B; Tyagi P; Tsukamoto T; Nelson J B; Glorioso J C; Chancellor M B; Yoshimura N
Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.
Gene therapy 2009;16(1):26-33.
2008: Srinivasan Rahul; Wolfe Darren; Goss James; Watkins Simon; de Groat William C; Sculptoreanu Adrian; Glorioso Joseph C
Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons.
The European journal of neuroscience 2008;28(7):1241-54.
2008: Srinivasan Rahul; Fink David J; Glorioso Joseph C
HSV vectors for gene therapy of chronic pain.
Current opinion in molecular therapeutics 2008;10(5):449-55.
2008: Li Han; Baskaran Rajasekaran; Krisky David M; Bein Kiflai; Grandi Paola; Cohen Justus B; Glorioso Joseph C
Chk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth.
Virology 2008;375(1):13-23.
2008: Goins William F; Krisky David M; Wechuck James B; Huang Shaohua; Glorioso Joseph C
Construction and production of recombinant herpes simplex virus vectors.
Methods in molecular biology (Clifton, N.J.) 2008;433():97-113.
2007: McTiernan C F; Mathier M A; Zhu X; Xiao X; Klein E; Swan C H; Mehdi H; Gibson G; Trichel A M; Glorioso J C; Feldman A M; McCurry K R; London B
Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.
Gene therapy 2007;14(23):1613-22.
2007: Wolfe Darren; Hao Shuanglin; Hu Jian; Srinivasan Rahul; Goss James; Mata Marina; Fink David J; Glorioso Joseph C
Engineering an endomorphin-2 gene for use in neuropathic pain therapy.
Pain 2007;133(1-3):29-38.
2007: Wolfe Darren; Hao Shuanglin; Hu Jian; Srinivasan Rahul; Goss James; Mata Marina; Fink David J; Glorioso Joseph C
Engineering an endomorphin-2 gene for use in neuropathic pain therapy.
Pain 2007;133(1-3):29-38.
2007: Frampton Arthur R; Stolz Donna B; Uchida Hiroaki; Goins William F; Cohen Justus B; Glorioso Joseph C
Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.
Journal of virology 2007;81(20):10879-89.
2007: Srinivasan Rahul; Huang Shaohua; Chaudhry Suchita; Sculptoreanu Adrian; Krisky David; Cascio Michael; Friedman Peter A; de Groat William C; Wolfe Darren; Glorioso Joseph C
An HSV vector system for selection of ligand-gated ion channel modulators.
Nature methods 2007;4(9):733-9.
2007: Srinivasan Rahul; Huang Shaohua; Chaudhry Suchita; Sculptoreanu Adrian; Krisky David; Cascio Michael; Friedman Peter A; de Groat William C; Wolfe Darren; Glorioso Joseph C
An HSV vector system for selection of ligand-gated ion channel modulators.
Nature methods 2007;4(9):733-9.
2007: Kato R; Wolfe D; Coyle C H; Huang S; Wechuck J B; Goins W F; Krisky D M; Tsukamoto T; Nelson J B; Glorioso J C; Chancellor M B; Yoshimura N
Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury.
Gene therapy 2007;14(18):1344-52.
2007: Niranjan Ajay; Fellows Wendy; Stauffer William; Burton Edward A; Hong Chang-Sook; Lunsford L Dade; Kondziolka Douglas; Glorioso Joseph C; Gobbel Glenn T
Survival of transplanted neural progenitor cells enhanced by brain irradiation.
Journal of neurosurgery 2007;107(2):383-91.
2007: Chattopadhyay M; Mata M; Goss J; Wolfe D; Huang S; Glorioso J C; Fink D J
Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer.
Diabetologia 2007;50(7):1550-8.
2007: Hao S; Mata M; Glorioso J C; Fink D J
Gene transfer to interfere with TNFalpha signaling in neuropathic pain.
Gene therapy 2007;14(13):1010-6.
2007: Goss James R; Goins William F; Glorioso Joseph C
Gene therapy applications for the treatment of neuropathic pain.
Expert review of neurotherapeutics 2007;7(5):487-506.
2007: Tsvitov Marianna; Frampton Arthur R; Shah Waris A; Wendell Steven K; Ozuer Ali; Kapacee Zoher; Goins William F; Cohen Justus B; Glorioso Joseph C
Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection.
Virology 2007;360(2):477-91.
2006: Puskovic Veljko; Wolfe Darren; Wechuck James; Krisky David; Collins Jeff; Glorioso Joseph C; Fink David J; Mata Marina
HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(5):710-5.
2006: Jiang Canping; Ataai Mohammad; Ozuer Ali; Krisky David; Wechuck James; Pornsuwan Soraya; Pourarian Fazard; Glorioso Joseph C
Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: oxidative damage by hydroxyl free radicals and its prevention.
Biotechnology and bioengineering 2006;95(1):48-57.
2006: Jiang Canping; Glorioso Joseph C; Ataai Mohammad
Presence of imidazole in loading buffer prevents formation of free radical in immobilized metal affinity chromatography and dramatically improves the recovery of herpes simplex virus type 1 gene therapy vectors.
Journal of chromatography. A 2006;1121(1):40-5.
2006: Hong C-S; Goins W F; Goss J R; Burton E A; Glorioso J C
Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
Gene therapy 2006;13(14):1068-79.
2006: Peng Xiang-min; Zhou Zhi-gang; Glorioso Joseph C; Fink David J; Mata Marina
Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury.
Annals of neurology 2006;59(5):843-51.
2006: Kwon Heechung; Bai Qing; Baek Hyun-Jung; Felmet Kelly; Burton Edward A; Goins William F; Cohen Justus B; Glorioso Joseph C
Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D.
Journal of virology 2006;80(1):138-48.
2006: Hao Shuanglin; Mata Marina; Glorioso Joseph C; Fink David J
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.
Molecular pain 2006;2():6.
2005: Chattopadhyay M; Krisky D; Wolfe D; Glorioso J C; Mata M; Fink D J
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy.
Gene therapy 2005;12(18):1377-84.
2005: Burton Edward A; Fink David J; Glorioso Joseph C
Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
Current opinion in molecular therapeutics 2005;7(4):326-36.
2005: Chattopadhyay Munmun; Wolfe Darren; Mata Marina; Huang Shaohua; Glorioso Joseph C; Fink David J
Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(2):307-13.
2005: Hao Shuanglin; Mata Marina; Wolfe Darren; Huang Shaohua; Glorioso Joseph C; Fink David J
Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.
Annals of neurology 2005;57(6):914-8.
2005: Frampton A R; Goins W F; Nakano K; Burton E A; Glorioso J C
HSV trafficking and development of gene therapy vectors with applications in the nervous system.
Gene therapy 2005;12(11):891-901.
2005: Bennett Nelson E; Kim Jang H; Wolfe Darren P; Sasaki Katsumi; Yoshimura Naoki; Goins William F; Huang Shaohua; Nelson Joel B; de Groat William C; Glorioso Joseph C; Chancellor Michael B
Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats.
The Journal of urology 2005;173(5):1820-4.
2005: Nakano Kenji; Todo Tomoki; Zhao Gang; Yamaguchi Koji; Kuroki Syoji; Cohen Justus B; Glorioso Joseph C; Tanaka Masao
Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.
The journal of gene medicine 2005;7(5):638-48.
2005: Moriuchi Shusuke; Glorioso Joseph C; Maruno Motohiko; Izumoto Shuichi; Wolfe Darren; Huang Shaohua; Cohen Justus B; Yoshimine Toshiki
Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase.
Cancer gene therapy 2005;12(5):487-96.
2005: Nakano Kenji; Asano Ryutaro; Tsumoto Kouhei; Kwon Heechung; Goins William F; Kumagai Izumi; Cohen Justus B; Glorioso Joseph C
Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(4):617-26.
2005: Frampton Arthur R; Goins William F; Cohen Justus B; von Einem Jens; Osterrieder Nikolaus; O'Callaghan Dennis J; Glorioso Joseph C
Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.
Journal of virology 2005;79(5):3169-73.
2005: Koldamova Radosveta P; Lefterov Iliya M; Staufenbiel Matthias; Wolfe Darren; Huang Shaohua; Glorioso Joseph C; Walter Michael; Roth Michael G; Lazo John S
The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease.
The Journal of biological chemistry 2005;280(6):4079-88.
2005: Fradette J; Wolfe D; Goins W F; Huang S; Flanigan R M; Glorioso J C
HSV vector-mediated transduction and GDNF secretion from adipose cells.
Gene therapy 2005;12(1):48-58.
2004: Wolfe D; Niranjan A; Trichel A; Wiley C; Ozuer A; Kanal E; Kondziolka D; Krisky D; Goss J; Deluca N; Murphey-Corb M; Glorioso J C
Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates.
Gene therapy 2004;11(23):1675-84.
2004: Sasaki Katsumi; Chancellor Michael B; Goins William F; Phelan Michael W; Glorioso Joseph C; de Groat William C; Yoshimura Naoki
Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy.
Diabetes 2004;53(10):2723-30.
2004: Jiang Canping; Wechuck James B; Goins William F; Krisky David M; Wolfe Darren; Ataai Mohammad M; Glorioso Joseph C
Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification.
Journal of virology 2004;78(17):8994-9006.
2004: Puskovic Veljko; Wolfe Darren; Goss James; Huang Shaohua; Mata Marina; Glorioso Joseph C; Fink David J
Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(1):67-75.
2004: Liu Jun; Wolfe Darren; Hao Shuanglin; Huang Shaohua; Glorioso Joseph C; Mata Marina; Fink David J
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(1):57-66.
2004: Trybala Edward; Olofsson Sigvard; Mårdberg Kristina; Svennerholm Bo; Umemoto Kimiko; Glorioso Joseph C; Bergström Tomas
Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells.
Antiviral research 2004;62(3):125-34.
2004: Chattopadhyay Munmun; Goss James; Wolfe Darren; Goins William C; Huang Shaohua; Glorioso Joseph C; Mata Marina; Fink David J
Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy.
Brain : a journal of neurology 2004;127(Pt 4):929-39.
2004: Mata Marina; Glorioso Joseph C; Fink David J
Gene therapy: novel treatments for polyneuropathy and chronic pain.
Current neurology and neuroscience reports 2004;4(1):1-2.
2004: Glorioso Joseph C; Fink David J
Herpes vector-mediated gene transfer in treatment of diseases of the nervous system.
Annual review of microbiology 2004;58():253-71.
2004: Wolfe Darren; Wechuck James B; Krisky David M; Goff Julie P; Goins William F; Ozuer Ali; Epperly Michael E; Greenberger Joel S; Fink David J; Glorioso Joseph C
Delivery of herpes simplex virus-based vectors to stem cells.
Methods in molecular biology (Clifton, N.J.) 2004;246():339-52.
2004: Niranjan Ajay; Wolfe Darren; Fellows Wendy; Goins William F; Glorioso Joseph C; Kondziolka Douglas; Lunsford L Dade
Gene transfer to glial tumors using herpes simplex virus.
Methods in molecular biology (Clifton, N.J.) 2004;246():323-37.
2004: Goss James R; Natsume Atsushi; Wolfe Darren; Mata Marina; Glorioso Joseph C; Fink David J
Delivery of herpes simplex virus-based vectors to the nervous system.
Methods in molecular biology (Clifton, N.J.) 2004;246():309-22.
2004: Goins William F; Wolfe Darren; Krisky David M; Bai Qing; Burton Ed A; Fink David J; Glorioso Joseph C
Delivery using herpes simplex virus: an overview.
Methods in molecular biology (Clifton, N.J.) 2004;246():257-99.
2003: Natsume Atsushi; Wolfe Darren; Hu Jian; Huang Shaohua; Puskovic Veljko; Glorioso Joseph C; Fink David J; Mata Marina
Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer.
Experimental neurology 2003;184(2):878-86.
2003: Mata Marina; Glorioso Joseph C; Fink David J
Gene transfer to the nervous system: prospects for novel treatments directed at diseases of the aging nervous system.
The journals of gerontology. Series A, Biological sciences and medical sciences 2003;58(12):M1111-8.
2003: Glorioso Joseph C; Mata Marina; Fink David J
Exploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors.
Expert opinion on biological therapy 2003;3(8):1233-9.
2003: Mata Marina; Glorioso Joseph; Fink David J
Development of HSV-mediated gene transfer for the treatment of chronic pain.
Experimental neurology 2003;184 Suppl 1():S25-9.
2003: Fink David J; Glorioso Joseph; Mata Marina
Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regeneration.
Experimental neurology 2003;184 Suppl 1():S19-24.
2003: Glorioso Joseph C; Mata Marina; Fink David J
Gene therapy for chronic pain.
Current opinion in molecular therapeutics 2003;5(5):483-8.
2003: Niranjan Ajay; Wolfe Darren; Tamura Masakazu; Soares M Karina; Krisky David M; Lunsford L Dade; Li Songhui; Fellows-Mayle Wendy; DeLuca Neal A; Cohen Justus B; Glorioso Joseph C
Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(4):530-42.
2003: Hao Shuanglin; Mata Marina; Wolfe Darren; Huang Shaohua; Glorioso Joseph C; Fink David J
HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(3):367-75.
2003: Burton E A; Glorioso J C; Fink D J
Gene therapy progress and prospects: Parkinson's disease.
Gene therapy 2003;10(20):1721-7.
2003: Fink David; Mata Marina; Glorioso Joseph C
Cell and gene therapy in the treatment of pain.
Advanced drug delivery reviews 2003;55(8):1055-64.
2003: Kohn Donald B; Sadelain Michel; Dunbar Cynthia; Bodine David; Kiem Hans-Peter; Candotti Fabio; Tisdale John; Riviére Isabelle; Blau C Anthony; Richard Robert E; Sorrentino Brian; Nolta Jan; Malech Harry; Brenner Malcolm; Cornetta Kenneth; Cavagnaro Joy; High Katherine; Glorioso Joseph;
American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(2):180-7.
2003: Misumi Motohiro; Suzuki Toshiya; Moriuchi Shusuke; Glorioso Joseph C; Bessho Masami
In vitro thymidine kinase/ganciclovir-based suicide gene therapy using replication defective herpes simplex virus-1 against leukemic B-cell malignancies (MCL, HCL, B-CLL).
Leukemia research 2003;27(8):695-9.
2003: Kohn Donald B; Sadelain Michel; Glorioso Joseph C
Occurrence of leukaemia following gene therapy of X-linked SCID.
Nature reviews. Cancer 2003;3(7):477-88.
2003: Yao Q; Wang S; Gambotto A; Glorioso J C; Evans C H; Robbins P D; Ghivizzani S C; Oligino T J
Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
Gene therapy 2003;10(12):1055-60.
2003: Glorioso Joseph C; Mata Marina; Fink David J
Therapeutic gene transfer to the nervous system using viral vectors.
Journal of neurovirology 2003;9(2):165-72.
2003: Hao Shuanglin; Mata Marina; Goins William; Glorioso Joseph C; Fink David J
Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain.
Pain 2003;102(1-2):135-42.
2003: Burton Edward A; Hong Chang-Sook; Glorioso Joseph C
The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells.
Journal of virology 2003;77(6):3516-30.
2003: Chattopadhyay Munmun; Goss James; Lacomis David; Goins William C; Glorioso Joseph C; Mata Marina; Fink David J
Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals.
The European journal of neuroscience 2003;17(4):732-40.
2003: Guo Hong Liang; Wolfe Darren; Epperly Michael W; Huang Shaohua; Liu Kaihong; Glorioso Joseph C; Greenberger Joel; Blumberg David
Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(2):229-35; discussion 235-6.
2003: Mi Zhibao; Ghivizzani Steven C; Lechman Eric; Glorioso Joseph C; Evans Christopher H; Robbins Paul D
Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees.
Arthritis research & therapy 2003;5(3):R132-9.
2003: Burton Edward A; Huang Shaohua; Goins William F; Glorioso Joseph C
Use of the herpes simplex viral genome to construct gene therapy vectors.
Methods in molecular medicine 2003;76():1-31.
2002: Burton Edward A; Fink David J; Glorioso Joseph C
Gene delivery using herpes simplex virus vectors.
DNA and cell biology 2002;21(12):915-36.
2002: Mata Marina; Glorioso Joseph C; Fink David J
Targeted gene delivery to the nervous system using herpes simplex virus vectors.
Physiology & behavior 2002;77(4-5):483-8.
2002: Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis A M; Marino R; Glorioso J C; Yoshimine T
Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
Gene therapy 2002;9(24):1653-8.
2002: Goss James R; Harley Cara F; Mata Marina; O'Malley Mark E; Goins William F; Hu XiaoPing; Glorioso Joseph C; Fink David J
Herpes vector-mediated expression of proenkephalin reduces bone cancer pain.
Annals of neurology 2002;52(5):662-5.
2002: Burton Edward A; Bai Qing; Goins William F; Glorioso Joseph C
Replication-defective genomic herpes simplex vectors: design and production.
Current opinion in biotechnology 2002;13(5):424-8.
2002: Goins William F; Marconi Peggy; Krisky David; Wolfe Darren; Glorioso Joseph C; Ramakrishnan Ramesh; Fink David J
Construction of replication-defective herpes simplex virus vectors.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2002;Chapter 12():Unit 12.11.
2002: Wechuck James B; Ozuer Ali; Goins William F; Wolfe Darren; Oligino Thomas; Glorioso Joseph C; Ataai Mohammad M
Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors.
Biotechnology and bioengineering 2002;79(1):112-9.
2002: Goss James R; Goins William F; Lacomis David; Mata Marina; Glorioso Joseph C; Fink David J
Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse.
Diabetes 2002;51(7):2227-32.
2002: Chen Xiao-Ping; Mata Marina; Kelley Mary; Glorioso Joseph C; Fink David J
The relationship of herpes simplex virus latency associated transcript expression to genome copy number: a quantitative study using laser capture microdissection.
Journal of neurovirology 2002;8(3):204-10.
2002: Ozuer Ali; Wechuck James B; Russell Brian; Wolfe Darren; Goins William F; Glorioso Joseph C; Ataai Mohammad M
Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors.
Biotechnology progress 2002;18(3):476-82.
2002: Moriuchi S; Wolfe D; Tamura M; Yoshimine T; Miura F; Cohen J B; Glorioso J C
Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model.
Gene therapy 2002;9(9):584-91.
2002: Glorioso Joseph C; Fink David J
Use of HSV vectors to modify the nervous system.
Current opinion in drug discovery & development 2002;5(2):289-95.
2002: Iwai Masaki; Harada Yoshinori; Ishii Michiaki; Kashima Kei; Mazda Osam; Tamura Masakazu; Wolfe Darren; Goin William F; Glorioso Joseph C
Suicide gene therapy of human hepatoma and its peritonitis carcinomatosis by a vector of replicative-deficient herpes simplex virus.
Biochemical and biophysical research communications 2002;291(4):855-60.
2002: Ozuer Ali; Wechuck James B; Goins William F; Wolfe Darren; Glorioso Joseph C; Ataai Mohammad M
Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors.
Biotechnology and bioengineering 2002;77(6):685-92.
2002: Natsume Atsushi; Mata Marina; Wolfe Darren; Oligino Thomas; Goss James; Huang Shaohua; Glorioso Joseph; Fink David J
Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect.
Journal of neurotrauma 2002;19(1):61-8.
2002: Chattopadhyay Munmun; Wolfe Darren; Huang Shaohua; Goss James; Glorioso Joseph C; Mata Marina; Fink David J
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3.
Annals of neurology 2002;51(1):19-27.
2002: Goins William F; Krisky David M; Wolfe Darren P; Fink David J; Glorioso Joseph C
Development of replication-defective herpes simplex virus vectors.
Methods in molecular medicine 2002;69():481-507.
2001: Burton E A; Bai Q; Goins W F; Glorioso J C
Targeting gene expression using HSV vectors.
Advanced drug delivery reviews 2001;53(2):155-70.
2001: Ruffini F; Furlan R; Poliani P L; Brambilla E; Marconi P C; Bergami A; Desina G; Glorioso J C; Comi G; Martino G
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
Gene therapy 2001;8(16):1207-13.
2001: Mårdberg K; Trybala E; Glorioso J C; Bergström T
Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C.
The Journal of general virology 2001;82(Pt 8):1941-50.
2001: Yao Q; Wang S; Glorioso J C; Evans C H; Robbins P D; Ghivizzani S C; Oligino T J
Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(6):901-10.
2001: Yoshimura N; Franks M E; Sasaki K; Goins W F; Goss J; Yokoyama T; Fraser M O; Seki S; Fink J; Glorioso J; de Groat W C; Chancellor M B
Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE).
Urology 2001;57(6 Suppl 1):116.
2001: Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink D J
Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
Experimental neurology 2001;169(2):231-8.
2001: Poliani P L; Brok H; Furlan R; Ruffini F; Bergami A; Desina G; Marconi P C; Rovaris M; Uccelli A; Glorioso J C; Penna G; Adorini L; Comi G; 't Hart B; Martino G
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.
Human gene therapy 2001;12(8):905-20.
2001: Goins W F; Yoshimura N; Phelan M W; Yokoyama T; Fraser M O; Ozawa H; Bennett N J R; de Groat W C; Glorioso J C; Chancellor M B
Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction.
The Journal of urology 2001;165(5):1748-54.
2001: Goss J R; Mata M; Goins W F; Wu H H; Glorioso J C; Fink D J
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion.
Gene therapy 2001;8(7):551-6.
2001: Yamada M; Natsume A; Mata M; Oligino T; Goss J; Glorioso J; Fink D J
Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion.
Experimental neurology 2001;168(2):225-30.
2001: Furlan R; Poliani P L; Marconi P C; Bergami A; Ruffini F; Adorini L; Glorioso J C; Comi G; Martino G
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
Gene therapy 2001;8(1):13-9.
2001: Wolfe D; Goins W F; Kaplan T J; Capuano S V; Fradette J; Murphey-Corb M; Robbins P D; Cohen J B; Glorioso J C
Herpesvirus-mediated systemic delivery of nerve growth factor.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(1):61-9.
2001: Burton E A; Wechuck J B; Wendell S K; Goins W F; Fink D J; Glorioso J C
Multiple applications for replication-defective herpes simplex virus vectors.
Stem cells (Dayton, Ohio) 2001;19(5):358-77.
2000: Arafat W O; Casado E; Wang M; Alvarez R D; Siegal G P; Glorioso J C; Curiel D T; Gómez-Navarro J
Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4442-8.
2000: Mi Z; Ghivizzani S C; Lechman E R; Jaffurs D; Glorioso J C; Evans C H; Robbins P D
Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints.
Arthritis and rheumatism 2000;43(11):2563-70.
2000: Chen X p; Li J; Mata M; Goss J; Wolfe D; Glorioso J C; Fink D J
Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture.
Journal of virology 2000;74(21):10132-41.
2000: Rouse R J; Seifried W; Mistry S K; Goins W F; Glorioso J C
Herpes simplex virus-enhanced cationic lipid/DNA-mediated transfection.
BioTechniques 2000;29(4):810-4.
2000: Moriuchi S; Krisky D M; Marconi P C; Tamura M; Shimizu K; Yoshimine T; Cohen J B; Glorioso J C
HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Gene therapy 2000;7(17):1483-90.
2000: Niranjan A; Moriuchi S; Lunsford L D; Kondziolka D; Flickinger J C; Fellows W; Rajendiran S; Tamura M; Cohen J B; Glorioso J C
Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(2):114-20.
2000: Glorioso J C; Huang L; Dunbar C; Felgner P L
Highlights from the third annual ASGT meeting. American Society of Gene Therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(2):96-100.
2000: Martino G; Poliani P L; Furlan R; Marconi P; Glorioso J C; Adorini L; Comi G
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach.
Journal of neuroimmunology 2000;107(2):184-90.
2000: Yao Q; Glorioso J C; Evans C H; Robbins P D; Kovesdi I; Oligino T J; Ghivizzani S C
Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining.
The journal of gene medicine 2000;2(3):210-9.
2000: Wechuck J B; Goins W F; Glorioso J C; Ataai M M
Effect of protease inhibitors on yield of HSV-1-based viral vectors.
Biotechnology progress 2000;16(3):493-6.
2000: Anderson D B; Laquerre S; Ghosh K; Ghosh H P; Goins W F; Cohen J B; Glorioso J C
Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.
Journal of virology 2000;74(5):2481-7.
2000: Marconi P; Tamura M; Moriuchi S; Krisky D M; Niranjan A; Goins W F; Cohen J B; Glorioso J C
Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(1):71-81.
2000: Gómez-Navarro J; Contreras J L; Arafat W; Jiang X L; Krisky D; Oligino T; Marconi P; Hubbard B; Glorioso J C; Curiel D T; Thomas J M
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model.
Gene therapy 2000;7(1):43-52.
2000: Fink D J; DeLuca N A; Yamada M; Wolfe D P; Glorioso J C
Design and application of HSV vectors for neuroprotection.
Gene therapy 2000;7(2):115-9.
2000: Glorioso J C
Perspectives on viral vector design and applications.
Advances in virus research 2000;55():403-7.
1999: Oligino T; Ghivizzani S; Wolfe D; Lechman E; Krisky D; Mi Z; Evans C; Robbins P; Glorioso J
Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.
Gene therapy 1999;6(10):1713-20.
1999: Wolfe D; Goins W F; Yamada M; Moriuchi S; Krisky D M; Oligino T J; Marconi P C; Fink D J; Glorioso J C
Engineering herpes simplex virus vectors for CNS applications.
Experimental neurology 1999;159(1):34-46.
1999: Marconi P; Simonato M; Zucchini S; Bregola G; Argnani R; Krisky D; Glorioso J C; Manservigi R
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo.
Gene therapy 1999;6(5):904-12.
1999: Alvira M R; Goins W F; Cohen J B; Glorioso J C
Genetic studies exposing the splicing events involved in herpes simplex virus type 1 latency-associated transcript production during lytic and latent infection.
Journal of virology 1999;73(5):3866-76.
1999: Yamada M; Oligino T; Mata M; Goss J R; Glorioso J C; Fink D J
Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(7):4078-83.
1999: Whalen J D; Lechman E L; Carlos C A; Weiss K; Kovesdi I; Glorioso J C; Robbins P D; Evans C H
Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3625-32.
1999: Goins W F; Lee K A; Cavalcoli J D; O'Malley M E; DeKosky S T; Fink D J; Glorioso J C
Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.
Journal of virology 1999;73(1):519-32.
1998: Krisky D M; Wolfe D; Goins W F; Marconi P C; Ramakrishnan R; Mata M; Rouse R J; Fink D J; Glorioso J C
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.
Gene therapy 1998;5(12):1593-603.
1998: Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso J C
Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
Cancer research 1998;58(24):5731-7.
1998: Laquerre S; Anderson D B; Stolz D B; Glorioso J C
Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.
Journal of virology 1998;72(12):9683-97.
1998: Krisky D M; Marconi P C; Oligino T J; Rouse R J; Fink D J; Cohen J B; Watkins S C; Glorioso J C
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.
Gene therapy 1998;5(11):1517-30.
1998: Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky D M; Oligino T; Glorioso J C; Curiel T J; Curiel D T
Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Biochemical and biophysical research communications 1998;252(3):686-90.
1998: Wang M; Rancourt C; Navarro J G; Krisky D; Marconi P; Oligino T; Alvarez R D; Siegal G P; Glorioso J C; Curiel D T
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector.
Gynecologic oncology 1998;71(2):278-87.
1998: Laquerre S; Argnani R; Anderson D B; Zucchini S; Manservigi R; Glorioso J C
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.
Journal of virology 1998;72(7):6119-30.
1998: Laquerre S; Anderson D B; Argnani R; Glorioso J C
Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles.
Journal of virology 1998;72(6):4940-9.
1998: Oligino T; Poliani P L; Wang Y; Tsai S Y; O'Malley B W; Fink D J; Glorioso J C
Drug inducible transgene expression in brain using a herpes simplex virus vector.
Gene therapy 1998;5(4):491-6.
1998: Kuklin N A; Daheshia M; Marconi P C; Krisky D M; Rouse R J; Glorioso J C; Manican E; Rouse B T
Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines.
Virology 1998;240(2):245-53.
1997: Krisky D M; Marconi P C; Oligino T; Rouse R J; Fink D J; Glorioso J C
Rapid method for construction of recombinant HSV gene transfer vectors.
Gene therapy 1997;4(10):1120-5.
1997: Rasty S; Poliani P L; Fink D J; Glorioso J C
Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system.
Journal of neurovirology 1997;3(4):247-64.
1997: Goins W F; Krisky D; Marconi P; Oligino T; Ramakrishnan R; Poliani P L; Fink D J; Glorioso J C
Herpes simplex virus vectors for gene transfer to the nervous system.
Journal of neurovirology 1997;3 Suppl 1():S80-8.
1997: Fink D J; Poliani P L; Oligino T; Krisky D M; Goins W F; Glorioso J C
Development of an HSV-based vector for the treatment of Parkinson's disease.
Experimental neurology 1997;144(1):103-21.
1997: Fink D J; Glorioso J C
Engineering herpes simplex virus vectors for gene transfer to neurons.
Nature medicine 1997;3(3):357-9.
1997: Huard J; Akkaraju G; Watkins S C; Pike-Cavalcoli M; Glorioso J C
LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
Human gene therapy 1997;8(4):439-52.
1997: Feero W G; Rosenblatt J D; Huard J; Watkins S C; Epperly M; Clemens P R; Kochanek S; Glorioso J C; Partridge T A; Hoffman E P
Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors.
Human gene therapy 1997;8(4):371-80.
1997: Glorioso J C; Goins W F; Schmidt M C; Oligino T; Krisky D M; Marconi P C; Cavalcoli J D; Ramakrishnan R; Poliani P L; Fink D J
Engineering herpes simplex virus vectors for human gene therapy.
Advances in pharmacology (San Diego, Calif.) 1997;40():103-36.
1996: Huard J; Feero W G; Watkins S C; Hoffman E P; Rosenblatt D J; Glorioso J C
The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers.
Journal of virology 1996;70(11):8117-23.
1996: Oligino T; Poliani P L; Marconi P; Bender M A; Schmidt M C; Fink D J; Glorioso J C
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16.
Gene therapy 1996;3(10):892-9.
1996: Marconi P; Krisky D; Oligino T; Poliani P L; Ramakrishnan R; Goins W F; Fink D J; Glorioso J C
Replication-defective herpes simplex virus vectors for gene transfer in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11319-20.
1996: French S W; Schmidt M C; Glorioso J C
Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2.
Molecular and cellular biology 1996;16(10):5393-9.
1996: Ramakrishnan R; Poliani P L; Levine M; Glorioso J C; Fink D J
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR.
Journal of virology 1996;70(9):6519-23.
1996: Soares K; Hwang D Y; Ramakrishnan R; Schmidt M C; Fink D J; Glorioso J C
cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo.
Journal of virology 1996;70(8):5384-94.
1996: Evans C H; Robbins P D; Ghivizzani S C; Herndon J H; Kang R; Bahnson A B; Barranger J A; Elders E M; Gay S; Tomaino M M; Wasko M C; Watkins S C; Whiteside T L; Glorioso J C; Lotze M T; Wright T M
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis.
Human gene therapy 1996;7(10):1261-80.
1996: Rasty S; Thatikunta P; Gordon J; Khalili K; Amini S; Glorioso J C
Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(12):6073-8.
1996: Laquerre S; Person S; Glorioso J C
Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain.
Journal of virology 1996;70(3):1640-50.
1996: Fink D J; DeLuca N A; Goins W F; Glorioso J C
Gene transfer to neurons using herpes simplex virus-based vectors.
Annual review of neuroscience 1996;19():265-87.
1995: Chen X; Schmidt M C; Goins W F; Glorioso J C
Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections.
Journal of virology 1995;69(12):7899-908.
1995: Glorioso J C; Bender M A; Goins W F; Fink D J; DeLuca N
HSV as a gene transfer vector for the nervous system.
Molecular biotechnology 1995;4(1):87-99.
1995: Huard J; Goins W F; Glorioso J C
Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Gene therapy 1995;2(6):385-92.
1995: Mester J C; Pitha P M; Glorioso J C
Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.
Gene therapy 1995;2(3):187-96.
1995: Glorioso J; Bender M A; Fink D; DeLuca N
Herpes simplex virus vectors.
Molecular and cell biology of human diseases series 1995;5():33-63.
1995: Fink D J; Ramakrishnan R; Marconi P; Goins W F; Holland T C; Glorioso J C
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Clinical neuroscience (New York, N.Y.) 1995;3(5):284-91.
1995: Glorioso J C; DeLuca N A; Fink D J
Development and application of herpes simplex virus vectors for human gene therapy.
Annual review of microbiology 1995;49():675-710.
1994: Desai P; Homa F L; Person S; Glorioso J C
A genetic selection method for the transfer of HSV-1 glycoprotein B mutations from plasmid to the viral genome: preliminary characterization of transdominance and entry kinetics of mutant viruses.
Virology 1994;204(1):312-22.
1994: Goins W F; Sternberg L R; Croen K D; Krause P R; Hendricks R L; Fink D J; Straus S E; Levine M; Glorioso J C
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
Journal of virology 1994;68(4):2239-52.
1994: Ramakrishnan R; Fink D J; Jiang G; Desai P; Glorioso J C; Levine M
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.
Journal of virology 1994;68(3):1864-73.
1994: Glorioso J C; Goins W F; DeLuca N; Fink D J
Development of herpes simplex virus as a gene transfer vector for the nervous system.
Gene therapy 1994;1 Suppl 1():S39.
1994: Glorioso J C; Goins W F; Meaney C A; Fink D J; DeLuca N A
Gene transfer to brain using herpes simplex virus vectors.
Annals of neurology 1994;35 Suppl():S28-34.
1994: Glorioso J C; Goins W F; Fink D J; DeLuca N A
Herpes simplex virus vectors and gene transfer to brain.
Developments in biological standardization 1994;82():79-87.
1993: Bandara G; Mueller G M; Galea-Lauri J; Tindal M H; Georgescu H I; Suchanek M K; Hung G L; Glorioso J C; Robbins P D; Evans C H
Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(22):10764-8.
1993: Desai P; Ramakrishnan R; Lin Z W; Osak B; Glorioso J C; Levine M
The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection.
Journal of virology 1993;67(10):6125-35.
1993: Oyan A M; Dolter K E; Langeland N; Goins W F; Glorioso J C; Haarr L; Crumpacker C S
Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C.
Journal of virology 1993;67(5):2434-41.
1993: Gage P J; Levine M; Glorioso J C
Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B.
Journal of virology 1993;67(4):2191-201.
1993: Desai P; DeLuca N A; Glorioso J C; Person S
Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA.
Journal of virology 1993;67(3):1357-64.
1992: Evans C H; Bandara G; Mueller G; Robbins P; Glorioso J C; Georgescu H I
Synovial cell transplants for gene transfer to joints.
Transplantation proceedings 1992;24(6):2966.
1992: Gage P J; Sauer B; Levine M; Glorioso J C
A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome.
Journal of virology 1992;66(9):5509-15.
1992: Dolter K E; Goins W F; Levine M; Glorioso J C
Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.
Journal of virology 1992;66(8):4864-73.
1992: Bandara G; Robbins P D; Georgescu H I; Mueller G M; Glorioso J C; Evans C H
Gene transfer to synoviocytes: prospects for gene treatment of arthritis.
DNA and cell biology 1992;11(3):227-31.
1992: Fink D J; Sternberg L R; Weber P C; Mata M; Goins W F; Glorioso J C
In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer.
Human gene therapy 1992;3(1):11-9.
1991: Highlander S L; Goins W F; Person S; Holland T C; Levine M; Glorioso J C
Oligomer formation of the gB glycoprotein of herpes simplex virus type 1.
Journal of virology 1991;65(8):4275-83.
1990: Kimmel K A; Dolter K E; Toth G M; Levine M; Glorioso J C
Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C.
Journal of virology 1990;64(8):4033-6.
1990: Langeland N; Oyan A M; Marsden H S; Cross A; Glorioso J C; Moore L J; Haarr L
Localization on the herpes simplex virus type 1 genome of a region encoding proteins involved in adsorption to the cellular receptor.
Journal of virology 1990;64(3):1271-7.
1990: Kikuchi G E; Glorioso J C; Nairn R
Cross-linking studies show that herpes simplex virus type 1 glycoprotein C molecules are clustered in the membrane of infected cells.
The Journal of general virology 1990;71 ( Pt 2)():455-8.
1990: Wu C T; Levine M; Homa F; Highlander S L; Glorioso J C
Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.
Journal of virology 1990;64(2):856-63.
1990: Weber P C; Levine M; Glorioso J C
Recombinogenic properties of herpes simplex virus type 1 DNA sequences resident in simian virus 40 minichromosomes.
Journal of virology 1990;64(1):300-6.
1990: Levine M; Krikos A; Glorioso J C; Homa F L
Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1).
Advances in experimental medicine and biology 1990;278():151-64.
1989: Palella T D; Hidaka Y; Silverman L J; Levine M; Glorioso J; Kelley W N
Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector.
Gene 1989;80(1):137-44.
1989: Chrisp C E; Sunstrum J C; Averill D R; Levine M; Glorioso J C
Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.
Laboratory investigation; a journal of technical methods and pathology 1989;60(6):822-30.
1989: Highlander S L; Dorney D J; Gage P J; Holland T C; Cai W; Person S; Levine M; Glorioso J C
Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration.
Journal of virology 1989;63(2):730-8.
1989: Hidaka Y; Kelley W N; Levine M; Glorioso J; Silverman L J; Palella T D
Expression of human hypoxanthine guanine phosphoribosyltransferase mRNA in brains of mice infected with a recombinant herpes simplex virus type 1.
Transactions of the Association of American Physicians 1989;102():91-100.
1988: Huff V; Cai W; Glorioso J C; Levine M
The carboxy-terminal 41 amino acids of herpes simplex virus type 1 glycoprotein B are not essential for production of infectious virus particles.
Journal of virology 1988;62(11):4403-6.
1988: Weber P C; Levine M; Glorioso J C
Simple assay for quantitation of Tn5 inversion events in Escherichia coli and use of the assay in determination of plasmid copy number.
Journal of bacteriology 1988;170(10):4972-5.
1988: Sunstrum J C; Chrisp C E; Levine M; Glorioso J C
Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system.
Virus research 1988;11(1):17-32.
1988: Weber P C; Challberg M D; Nelson N J; Levine M; Glorioso J C
Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity.
Cell 1988;54(3):369-81.
1988: Highlander S L; Cai W H; Person S; Levine M; Glorioso J C
Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.
Journal of virology 1988;62(6):1881-8.
1988: Homa F L; Glorioso J C; Levine M
A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene.
Genes & development 1988;2(1):40-53.
1987: Highlander S L; Sutherland S L; Gage P J; Johnson D C; Levine M; Glorioso J C
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
Journal of virology 1987;61(11):3356-64.
1987: Kikuchi G E; Baker S A; Merajver S D; Coligan J E; Levine M; Glorioso J C; Nairn R
Purification and structural characterization of herpes simplex virus glycoprotein C.
Biochemistry 1987;26(2):424-31.
1987: Bishop G A; McCurry L; Schwartz S A; Glorioso J C
Activation of human natural killer cells by herpes simplex virus type 1-infected cells.
Intervirology 1987;28(2):78-88.
1986: Marlin S D; Highlander S L; Holland T C; Levine M; Glorioso J C
Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.
Journal of virology 1986;59(1):142-53.
1985: Goldin A L; Sandri-Goldin R M; Glorioso J C; Levine M
Stable induction of a 51K cellular protein in neuronal cells surviving herpes simplex virus type 1 infection.
Virology 1985;142(2):398-405.
1985: Marlin S D; Holland T C; Levine M; Glorioso J C
Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
Journal of virology 1985;53(1):128-36.
1984: Kikuchi G E; Coligan J E; Holland T C; Levine M; Glorioso J C; Nairn R
Biochemical characterization of peptides from herpes simplex virus glycoprotein gC: loss of CNBr fragments from the carboxy terminus of truncated, secreted gC molecules.
Journal of virology 1984;52(3):806-15.
1984: Holland T C; Homa F L; Marlin S D; Levine M; Glorioso J
Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins.
Journal of virology 1984;52(2):566-74.
1984: Sandri-Goldin R M; Goldin A L; Glorioso J; Levine M
Herpes simplex virus thymidine kinase gene is stably maintained and expressed in cells transformed by protoplast fusion.
Somatic cell and molecular genetics 1984;10(2):129-38.
1984: Holland L E; Sandri-Goldin R M; Goldin A L; Glorioso J C; Levine M
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45.
Journal of virology 1984;49(3):947-59.
1983: Sandri-Goldin R M; Goldin A L; Holland L E; Glorioso J C; Levine M
Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product.
Molecular and cellular biology 1983;3(11):2028-44.
1983: Holland T C; Sandri-Goldin R M; Holland L E; Marlin S D; Levine M; Glorioso J C
Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay.
Journal of virology 1983;46(2):649-52.
1983: Glorioso J; Szczesiul M S; Marlin S D; Levine M
Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
Virology 1983;126(1):1-18.
1983: Holland T C; Marlin S D; Levine M; Glorioso J
Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
Journal of virology 1983;45(2):672-82.
1983: Sandri-Goldin R M; Goldin A L; Levine M; Glorioso J
High-efficiency transfer of DNA into eukaryotic cells by protoplast fusion.
Methods in enzymology 1983;101():402-11.
1981: Sandri-Goldin R M; Goldin A L; Levine M; Glorioso J C
High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion.
Molecular and cellular biology 1981;1(8):743-52.
1981: Goldin A L; Sandri-Goldin R M; Levine M; Glorioso J C
Cloning of herpes simplex virus type 1 sequences representing the whole genome.
Journal of virology 1981;38(1):50-8.

Sign-in to see more